Clinical Trials Logo

Filter by:
NCT ID: NCT04329286 Not yet recruiting - Clinical trials for Platelet Changes in Cases of Iron Overload

Platelet Changes in Cases of Chronic Iron Over Load

Start date: April 1, 2020
Phase:
Study type: Observational

Iron demand: The average daily demand to fit the cell biological metabolism is balanced between intake and lost which about 1-2 mg.

NCT ID: NCT04329377 Not yet recruiting - Clinical trials for Platelet Changes in Cases of Iron Overload

Platelet Changes in Cases of Iron Overload(IO)

Start date: April 1, 2020
Phase:
Study type: Observational

Iron demand: The average daily demand to fit the cell biological metabolism is balanced between intake and lost which about 1-2 mg.

NCT ID: NCT04332328 Not yet recruiting - Clinical trials for Diet in Ulcerative Colitis Patients

Study of Demographic and Dietary Profile in Patients With Ulcerative Colitis in Upper Egypt

Start date: April 1, 2020
Phase:
Study type: Observational

Diet is known to play role in the complex etiology of UC.Patient with UC tend to adapt unguided dietary habits without the guidance of a dietician or physician (Dejong,M.J 2019).so identification of nutritional gaps is needed to facilitate the development of evidence-based dietary guideline and subsequently give correct dietary advice to UC patients(Haskkey,N et al 2017).

NCT ID: NCT04333251 Not yet recruiting - Clinical trials for Pneumonia, Interstitial

Study Testing Convalescent Plasma vs Best Supportive Care

Start date: April 1, 2020
Phase: Phase 1
Study type: Interventional

Currently there are no proven treatment option for COVID-19. Human convalescent plasma is an option for COVID-19 treatment and could be available from people who have recovered and can donate plasma.

NCT ID: NCT04333693 Not yet recruiting - COVID-19 Clinical Trials

Outcomes of Vascular Surgery in COVID-19 Infection: National Cohort Study

Covid-VAS
Start date: April 1, 2020
Phase:
Study type: Observational [Patient Registry]

There is an urgent need to understand the outcomes of COVID-19 infected patients who undergo surgery, specially vascular surgery. Capturing real-world data and sharing Spanish national experience will inform the management of this complex group of patients who undergo surgery throughout the COVID-19 pandemic, improving their clinical care. The global community has recognised that rapid dissemination and completion of studies in COVID-19 infected patients is a high priority, so we encourage all stakeholders (local investigators, ethics committees, IRBs) to work as quickly as possible to approve this project. This investigator-led, non-commercial, non-interventional study is extremely low risk, or even zero risk. This study does not collect any patient identifiable information (including no dates) and data will not be analysed at hospital-level.

NCT ID: NCT04341051 Not yet recruiting - Clinical trials for Peripheral Artery Occlusive Disease

Sciatic Block Increases Regional Saturation in Peripheral Artery Occlusive Disease.

Start date: April 1, 2020
Phase:
Study type: Observational [Patient Registry]

We conducted Single-center prospective observational study to evaluate the improvement of peripheral vascular perfusion monitored with near-infrared spectroscopy, in patients undergoing endovascular surgery after performing sciatic nervous block.

NCT ID: NCT04341103 Not yet recruiting - COVID-19 Clinical Trials

AlloSure Guided Immuno-Optimization for COVID-19: An Early Experience

Al-COVE
Start date: April 1, 2020
Phase:
Study type: Observational

The utilization of AlloSure to help guide immunosuppression management in solid organ transplant recipients diagnosed with COVID-19

NCT ID: NCT03090048 Not yet recruiting - Acne Vulgaris Clinical Trials

Vitamin A and Azithromycin for Acne Vulgaris

Start date: April 1, 2021
Phase: Early Phase 1
Study type: Interventional

Patients seen with acne lesions not having responded to existing treatments will be offered a placebo or a topical preparation consisting of Vitamin A USP with or without Azithromycin for a duration of 4-6 months USP for the objective of resolving the lesions without systemic side effects and via weekly follow-ups.

NCT ID: NCT03908112 Not yet recruiting - Concussion Clinical Trials

Interventions for Convergence Insufficiency in Concussed Children

ICONICC
Start date: April 1, 2021
Phase: Phase 3
Study type: Interventional

The ICONICC Study is a randomized controlled clinical trial designed to compare the proportion of successful treatment outcomes between children assigned to standard concussion care only, standard concussion care plus simple convergence procedures, or standard concussion care plus office-based vergence/accommodative therapy in children aged 11 to 17 years with symptomatic post-concussion syndrome. Children with post-concussion syndrome (4-12 weeks post-concussion injury) and symptomatic CI will be randomized to a 12-week treatment program of either standard concussion care (SC), SC plus simple convergence procedures (SC+), or SC plus office-based vergence/accommodative therapy SC+OBVAT (1:1:1 ratio). The study will also compare the effect of treatment on clinical measures of both accommodation and vergence, symptom level/burden, health-related quality of life, clinical measures of saccadic eye movement, and objective eye movement measurements of disparity vergence, saccadic function, and accommodative function. The attainment of objective eye movement measures provides an opportunity to understand the underlying neurophysiology of the vergence and accommodative systems. Objective eye movement recordings are powerful because of the rich foundation from primate single-cell recordings that show a direct correlation with vergence and accommodative parameters in the supraoculomotor area of midbrain2, 3 and the oculomotor vermis of the cerebellum.4, 5 Thus, a combined approach of acquiring both clinical vision function measures and objective eye movement recordings in children with PCS-CI may lead to better characterization of the oculomotor phenotype with subsequent improved and personalized therapeutic interventions.

NCT ID: NCT04017182 Not yet recruiting - Clinical trials for Central Venous Oxygen Saturation

Correlation Between External Jugular Venous and Superior Vena Cava Central Venous Blood Oxygen Saturation in Patient Under General Anesthesia

Start date: April 1, 2021
Phase:
Study type: Observational

After installation of central venous catheter in patients under general anesthesia, paired sample of superior vena cava central venous blood and right external jugular venous blood will be collected and send to central laboratory for venous blood gas analysis. Correlation between superior vena cava central venous blood and right external jugular venous blood oxygen saturation will be determined as primary outcome.